Benzinga
Search documents
These Analysts Cut Their Forecasts On Axon After Q4 Results
Benzinga· 2026-02-25 15:38
Axon Enterprise Inc (NASDAQ:AXON) reported better-than-expected fourth-quarter financial results and issued FY26 sales guidance above estimates on Tuesday.Axon posted fourth-quarter revenue of $796.72 million, beating analyst estimates of $755.40 million. The company reported fourth-quarter adjusted earnings of $2.15 per share, beating estimates of $1.60 per share, according to Benzinga Pro."Our momentum is accelerating as we enter 2026, supported by disciplined investment, strong product market fit and dee ...
CoStar Group Analysts Cut Their Forecasts Following Q4 Results - CoStar Group (NASDAQ:CSGP)
Benzinga· 2026-02-25 15:33
CoStar Group Inc (NASDAQ:CSGP) reported upbeat fourth-quarter financial results and issued FY26 adjusted EPS guidance with its midpoint below estimates.CoStar reported quarterly earnings of 31 cents per share which beat the analyst consensus estimate of 27 cents per share. The company reported quarterly sales of $900.000 million which beat the analyst consensus estimate of $885.967 million.CoStar Group affirmed FY2026 adjusted EPS guidance of $1.22-$1.33 and affirmed sales guidance of $3.780 billion-$3.820 ...
CoStar Group Analysts Cut Their Forecasts Following Q4 Results
Benzinga· 2026-02-25 15:33
CoStar Group Inc (NASDAQ:CSGP) reported upbeat fourth-quarter financial results and issued FY26 adjusted EPS guidance with its midpoint below estimates.CoStar reported quarterly earnings of 31 cents per share which beat the analyst consensus estimate of 27 cents per share. The company reported quarterly sales of $900.000 million which beat the analyst consensus estimate of $885.967 million.CoStar Group affirmed FY2026 adjusted EPS guidance of $1.22-$1.33 and affirmed sales guidance of $3.780 billion-$3.820 ...
What's Going On With Zeta Global Shares Today? - Zeta Global Holdings (NYSE:ZETA)
Benzinga· 2026-02-25 15:30
Zeta Global Holdings Corp. (NYSE:ZETA) shares are trading higher on Wednesday.Yesterday, the firm reported its fourth-quarter earnings. Zeta Global reported quarterly revenue of $394.64 million, which beat the Street estimate of $379.23 million and was a 25.41% increase over revenue of $314.67 million from the same period last year. Zeta expects fiscal 2026 revenue of $1.75 billion to $1.76 billion, versus the $1.72 billion analyst estimate.In the company’s quarterly conference call, Co-founder and CEO Davi ...
Acadia Healthcare Posts Upbeat Q4 Earnings, Joins Circle Internet, Resideo Technologies And Other Big Stocks Moving Higher On Wednesday - Acadia Healthcare Co (NASDAQ:ACHC), Albemarle (NYSE:ALB)
Benzinga· 2026-02-25 15:16
U.S. stocks were higher, with the Nasdaq Composite gaining around 1% on Wednesday.Acadia Healthcare reported quarterly earnings of 7 cents per share which beat the analyst consensus estimate of 6 cents per share. The company reported quarterly sales of $821.459 million which beat the analyst consensus estimate of $800.065 million.Acadia Healthcare shares jumped 23.5% to $21.27 on Wednesday.Here are some other big stocks recording gains in today’s session.Photo via Shutterstock ...
Chevron Unusual Options Activity - Chevron (NYSE:CVX)
Benzinga· 2026-02-25 15:00
Financial giants have made a conspicuous bullish move on Chevron. Our analysis of options history for Chevron (NYSE:CVX) revealed 8 unusual trades.Delving into the details, we found 37% of traders were bullish, while 0% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $323,680, and 3 were calls, valued at $367,240.Projected Price TargetsAfter evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band betwe ...
Transcript: Matson Q4 2025 Earnings Conference Call - Matson (NYSE:MATX)
Benzinga· 2026-02-25 15:00
Transcript: Matson Q4 2025 Earnings Conference Callby Benzinga Insights Benzinga Staff WriterFollowMatson (NYSE:MATX) reported fourth-quarter financial results on Tuesday. The transcript from the company's fourth-quarter earnings call has been provided below.Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more.The full earnings call is available at https://edge.media-server.com/mmc/p/dacgw6mk/Full TranscriptOPERATORSarah ...
Dow Jumps 200 Points; Lowe's Issues Weak Earnings Outlook - CASI Pharmaceuticals (NASDAQ:CASI), Lowe's Companies (NYSE:LOW)
Benzinga· 2026-02-25 14:55
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Wednesday.Following the market opening Wednesday, the Dow traded up 0.41% to 49,375.99 while the NASDAQ surged 0.77% to 23,040.20. The S&P 500 also rose, gaining, 0.55% to 6,928.15.Check This Out: How To Earn $500 A Month From Goldman Sachs Stock Ahead Of Q4 EarningsLeading and Lagging SectorsInformation technology shares gained by 0.8% on Wednesday.In trading on Wednesday, energy stocks fell by 0.3%.Top Headlin ...
Nvidia Earnings Prediction Market Preview: What Will Jensen Huang Say? - NVIDIA (NASDAQ:NVDA)
Benzinga· 2026-02-25 14:42
Nvidia Corp. (NASDAQ:NVDA) reports fiscal Q4 earnings after the bell today. The company has topped revenue estimates for 13 consecutive quarters and earnings estimates for 12 straight quarters.What Prediction Markets Are SayingThis explains why Polymarket gives a 93% chance the company beats the EPS consensus.The more interesting action is on Kalshi, where traders are betting real money on which specific words Jensen Huang and his team will say on the 5 p.m. ET call. The word list reads like a cheat sheet f ...
Ozempic Price War - Novo Nordisk Slashes Prices By 50%
Benzinga· 2026-02-25 14:13
Novo Nordisk A/S (NYSE:NVO) shares are down during Wednesday’s premarket session. The down move comes as the company announced plans to cut the list prices of its GLP-1 drugs by up to 50% in the U.S. starting in 2027, adding pressure as broader markets edged lower.Novo Nordisk Announces Major GLP-1 Drug Price CutsThe price reduction, announced on Tuesday, will affect popular medications such as Wegovy, Ozempic, and Rybelsus, with the new list price set at $675 per month, down from current prices ranging fro ...